Chronic chymase inhibition preserves cardiac function after left ventricular repair in rats☆
Author(s) -
Hideo Kanemitsu,
Shinji Takaı̈,
Hiroshi Tsuneyoshi,
Eiji Yoshikawa,
Tomohiro Nishina,
Mizuo Miyazaki,
Tadashi Ikeda,
M Komeda
Publication year - 2007
Publication title -
european journal of cardio-thoracic surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.303
H-Index - 133
eISSN - 1873-734X
pISSN - 1010-7940
DOI - 10.1016/j.ejcts.2007.09.040
Subject(s) - chymase , medicine , cardiology , ventricular remodeling , fibrosis , myocardial fibrosis , cardiac function curve , ventricular pressure , heart failure , blood pressure , endocrinology , mast cell , immunology
Although left ventricular repair (LVR) has been widely performed, the initial improvement of LV function does not last because of LV remodeling. Recent studies have demonstrated that chymase, a local enzyme in the heart, promotes angiotensin II formation as well as activation of transforming growth factor (TGF)-beta, both of which facilitate myocardial fibrosis. Therefore, chymase blockade may play an important role in the prevention of cardiac remodeling after LVR. In this study, the effects of chronic chymase inhibition (Chy-I) after LVR were evaluated in a rat LV aneurysm model.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom